Adjuvant systemic treatment for elderly breast cancer patients; addressing safety concerns.

摘要: Introduction: The issue of systemic treatment for early breast cancer in the elderly has always been challenging and spite clear evidence potential benefits adjuvant older women, they are usually undertreated with consequence worse outcomes. Areas covered: This article will review surrounding various options armamentarium early-stage patients. risks benefits, particular attention to a number newly introduced targeted agents, along role incorporating combined geriatric/oncologic assessment as routine part management patients considered. Expert opinion: Administration available (neo)adjuvant endocrine, chemo, well therapeutics fit is feasible tolerable; however, input from geriatric medicine psycho-oncology experts training o...